Dominick Colangelo Vericel Corp (VCEL) insider trading activity

Dominick Colangelo is President and CEO of Vericel Corp. Currently has a direct ownership of 259,997 shares of VCEL, which is worth approximately $12.9 Million. The most recent transaction as insider was on Feb 24, 2025, when has been sold 8,459 shares (Common Stock) at a price of $52.33 per share, resulting in proceeds of $442,659. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 260K

17.68% 3M change

33.42% 12M change

Total Value Held $12.9 Million

Dominick Colangelo Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 24 2025	SELL Payment of exercise price or tax liability	$442,659 $52.33 p/Share	8,459 Reduced 3.15%	259,997 Common Stock
Feb 24 2025	BUY Exercise of conversion of derivative security	-	18,250 Added 6.37%	268,456 Common Stock
Feb 19 2025	SELL Payment of exercise price or tax liability	$242,444 $57.78 p/Share	4,196 Reduced 1.65%	250,206 Common Stock
Feb 19 2025	BUY Exercise of conversion of derivative security	-	8,938 Added 3.39%	254,402 Common Stock
Feb 18 2025	SELL Payment of exercise price or tax liability	$310,629 $57.28 p/Share	5,423 Reduced 2.16%	245,464 Common Stock
Feb 18 2025	BUY Exercise of conversion of derivative security	-	29,950 Added 10.66%	250,887 Common Stock
Nov 14 2024	SELL Open market or private sale	$943,775 $53.93 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Nov 14 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Nov 13 2024	SELL Open market or private sale	$972,475 $55.57 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Nov 13 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Oct 17 2024	SELL Open market or private sale	$705,950 $40.34 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Oct 17 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Oct 16 2024	SELL Open market or private sale	$724,150 $41.38 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Oct 16 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Sep 12 2024	SELL Open market or private sale	$768,250 $43.9 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Sep 12 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Sep 11 2024	SELL Open market or private sale	$758,975 $43.37 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Sep 11 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Aug 15 2024	SELL Open market or private sale	$809,200 $46.24 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Aug 15 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Aug 14 2024	SELL Open market or private sale	$790,475 $45.17 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Aug 14 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Jul 18 2024	SELL Open market or private sale	$899,500 $51.4 p/Share	17,500 Reduced 7.34%	220,937 Common Stock
Jul 18 2024	BUY Exercise of conversion of derivative security	$52,850 $3.02 p/Share	17,500 Added 6.84%	238,437 Common Stock
Jul 17 2024	SELL Open market or private sale	$902,125 $51.55 p/Share	17,500 Reduced 7.34%	220,937 Common Stock

Also insider at

TRVI

Trevi Therapeutics, Inc. Healthcare